Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
What Maravai LifeSciences (MRVI) Said on Its Q3 Earnings Callmarketbeat.com
Maravai LifeSciences (NASDAQ:MRVI) raised its 2026 revenue and adjusted EBITDA forecasts after reporting third-quarter sales growth of 10%, driven by demand for mRNA products and continued growth at its Cygnus business.
The life sciences company reported revenue of $45.9 million for the quarter. It
Via MarketBeat · November 4, 2026
LeMaitre Vascular Q3 Earnings Call Highlightsmarketbeat.com
LeMaitre Vascular (NASDAQ:LMAT) reported 12% organic sales growth in the third quarter of 2026, driven by higher prices and unit volumes, while reiterating its full-year organic growth outlook and lowering its gross margin forecast.
CEO George LeMaitre said on the Nov. 4 earnings call that organic
Via MarketBeat · November 4, 2026
Unilever Targets 4%-6% Sales Growth and Higher Margins After Foods Separationmarketbeat.com
Unilever (NYSE:UL) set out a plan to grow annual underlying sales by 4% to 6%, with at least 2% volume growth, as it prepares to focus on beauty, personal care and home care following the planned separation of its Foods business.
At its capital markets day in New York, executives said they would co
Via MarketBeat · November 4, 2026
Inseego Q3 Earnings Call Highlightsmarketbeat.com
Inseego (NASDAQ:INSG) reported third-quarter revenue of $33.3 million and outlined a weaker near-term outlook for its North American business as a delayed fixed wireless access product launch and elevated carrier inventories weigh on orders.
The wireless broadband company also expects its newly acq
Via MarketBeat · November 4, 2026
What Mineralys Therapeutics (MLYS) Said on Its Q3 Earnings Callmarketbeat.com
Mineralys Therapeutics (NASDAQ:MLYS) is preparing to launch its hypertension drug candidate lorundrostat if it wins regulatory approval, with a U.S. Food and Drug Administration decision targeted for Dec. 22, executives said on the company’s third-quarter earnings call.
CEO Jon Congleton said discu
Via MarketBeat · November 4, 2026
Ionic Digital Q3 Earnings Call Highlightsmarketbeat.com
Ionic Digital (NASDAQ:IOND) reported third-quarter revenue of $49 million and net income of $17 million as the company works to secure customers for its remaining data center capacity in Texas.
On the earnings call, Chief Executive Officer Andy Stewart said Ionic’s top priority is putting approxima
Via MarketBeat · November 4, 2026
What News (NWS) Said on Its Q1 Earnings Callmarketbeat.com
News (NASDAQ:NWS) reported higher revenue and profit for its fiscal first quarter of 2027, as growth at Dow Jones, digital real estate and book publishing offset a weaker performance in its news media division.
Revenue rose 6% from a year earlier to $2.3 billion, while total segment EBITDA increase
Via MarketBeat · November 4, 2026
MercadoLibre Q3 Earnings Call Highlightsmarketbeat.com
MercadoLibre (NASDAQ:MELI) reported 41% year-over-year growth in net revenue and financial income on a foreign-exchange-neutral basis for the quarter ended September 30, 2026, as growth in Brazil and its financial technology business helped offset pressure on operating margins.
Operating income was
Via MarketBeat · November 4, 2026
Magnite Q3 Earnings Call Highlightsmarketbeat.com
Magnite (NASDAQ:MGNI) raised its full-year outlook after third-quarter growth in connected television and stronger-than-expected political advertising helped the advertising technology company exceed its financial targets.
Contribution excluding traffic acquisition costs, a non-GAAP measure known a
Via MarketBeat · November 4, 2026
What NETGEAR (NTGR) Said on Its Q3 Earnings Callmarketbeat.com
NETGEAR (NASDAQ:NTGR) reported a 9.3% decline in third-quarter revenue as manufacturing delays limited its ability to fill orders, even as demand grew for its enterprise networking products. The company said it expects supply constraints to persist into early 2027.
Revenue for the third quarter of
Via MarketBeat · November 4, 2026
What Evolus (EOLS) Said on Its Q3 Earnings Callmarketbeat.com
Evolus (NASDAQ:EOLS) reported third-quarter revenue of $78 million, up 13% from a year earlier, as sales of its injectable products grew and the company posted its fourth consecutive quarter of positive adjusted EBITDA.
The aesthetics company reaffirmed its 2026 revenue forecast and lowered its out
Via MarketBeat · November 4, 2026
What Fastly (FSLY) Said on Its Q3 Earnings Callmarketbeat.com
Fastly (NASDAQ:FSLY) reported record third-quarter revenue of $190.2 million and raised its full-year outlook, as increased traffic from large customers and security product sales helped drive a fourth consecutive quarter of revenue growth of at least 20%.
Revenue rose 20% from a year earlier and e
Via MarketBeat · November 4, 2026
Dave Q3 Earnings Call Highlightsmarketbeat.com
Dave (NASDAQ:DAVE) raised its full-year revenue and profit outlook after third-quarter revenue rose 31% from a year earlier, supported by record member additions, higher revenue per user and increased ExtraCash originations.
The financial technology company reported revenue of $198 million for the
Via MarketBeat · November 4, 2026
What Encore Capital Group (ECPG) Said on Its Q3 Earnings Callmarketbeat.com
Encore Capital Group (NASDAQ:ECPG) reported record collections and higher third-quarter earnings, as the debt buyer increased its full-year collections outlook and projected continued earnings growth in 2027.
Global collections rose 14% from a year earlier to $754 million, while net income increase
Via MarketBeat · November 4, 2026
8X8 Q2 Earnings Call Highlightsmarketbeat.com
8X8 (NASDAQ:EGHT) raised its fiscal 2027 revenue, earnings and operating cash flow outlook after reporting a sixth consecutive quarter of year-over-year revenue growth, driven in part by demand for usage-based communications services.
For the fiscal second quarter ended in September, total revenue
Via MarketBeat · November 4, 2026
Cytokinetics Q3 Earnings Call Highlightsmarketbeat.com
Cytokinetics (NASDAQ:CYTK) reported $44.5 million in third-quarter net revenue from heart drug MYQORZO, up 76% from the prior quarter, as the company prepares regulatory submissions that could expand the treatment’s use.
President and CEO Robert Blum said the launch, nearly nine months in, continue
Via MarketBeat · November 4, 2026
What Allegiant Travel (ALGT) Said on Its Q3 Earnings Callmarketbeat.com
Allegiant Travel (NASDAQ:ALGT) reported a narrower operating margin improvement and a slight adjusted loss for the third quarter of 2026, as strong leisure demand and higher fares helped offset a sharp increase in fuel costs.
The airline maintained its forecast for full-year adjusted earnings of mo
Via MarketBeat · November 4, 2026
What Chime Financial (CHYM) Said on Its Q3 Earnings Callmarketbeat.com
Chime Financial (NASDAQ:CHYM) reported accelerating revenue growth and its third consecutive quarter of GAAP net income in the third quarter of 2026, as its Prime membership tier and lending products helped lift revenue per active member.
Revenue rose 32% from a year earlier to $718 million, compar
Via MarketBeat · November 4, 2026
What ARM (ARM) Said on Its Q2 Earnings Callmarketbeat.com
ARM (NASDAQ:ARM) reported record second-quarter fiscal 2027 revenue as licensing demand and data center royalties grew, while executives said they had greater confidence in the sales potential of the company’s forthcoming Arm AGI CPU.
Revenue rose 27% year over year to $1.44 billion, marking Arm’s
Via MarketBeat · November 4, 2026
What GRAIL (GRAL) Said on Its Q3 Earnings Callmarketbeat.com
GRAIL (NASDAQ:GRAL) reported 4% revenue growth for the third quarter of 2026 as higher testing volumes were offset in part by lower prices, and said it expects a U.S. regulatory decision on its Galleri cancer screening test by early in the first quarter of 2027.
The company reported revenue of $37.
Via MarketBeat · November 4, 2026
electroCore Q3 Earnings Call Highlightsmarketbeat.com
electroCore (NASDAQ:ECOR) reported record third-quarter sales and a narrower loss, but revised its 2026 revenue outlook as changes to its sales organization took longer than expected to reach the full field.
The medical device company reported revenue of $9.7 million for the quarter ended Sept. 30,
Via MarketBeat · November 4, 2026
Caris Life Sciences Q3 Earnings Call Highlightsmarketbeat.com
Caris Life Sciences (NASDAQ:CAI) raised its full-year revenue outlook after third-quarter sales rose 27%, as growth in cancer-testing volumes accelerated for a second consecutive quarter. The company also reported lower quarterly profit as it increased spending on its sales force, marketing and new
Via MarketBeat · November 4, 2026
What Amplitude (AMPL) Said on Its Q3 Earnings Callmarketbeat.com
Amplitude (NASDAQ:AMPL) reported third-quarter revenue of $111 million, up 25% from a year earlier, and raised its full-year outlook as enterprise customers adopted more of its analytics and experimentation products.
The company recorded non-GAAP operating income of $5.7 million, its highest quarte
Via MarketBeat · November 4, 2026
Barrett Business Services Q3 Earnings Call Highlightsmarketbeat.com
Barrett Business Services (NASDAQ:BBSI) reported higher third-quarter gross billings but lower earnings per share as new client additions were offset by workforce reductions among existing customers and smaller favorable workers’ compensation adjustments.
The company lowered its full-year outlook f
Via MarketBeat · November 4, 2026
What Expedia Group (EXPE) Said on Its Q3 Earnings Callmarketbeat.com
Expedia Group (NASDAQ:EXPE) raised its full-year 2026 outlook after third-quarter bookings and revenue grew by double digits, though executives expect growth to moderate in the fourth quarter as travel disruptions, tougher comparisons and the timing of a promotion weigh on results.
Gross bookings r
Via MarketBeat · November 4, 2026
What ACADIA Pharmaceuticals (ACAD) Said on Its Q3 Earnings Callmarketbeat.com
ACADIA Pharmaceuticals (NASDAQ:ACAD) reported third-quarter 2026 revenue of $342 million, up 22% from a year earlier on an adjusted basis, as demand for its Rett syndrome treatment DAYBUE and Parkinson’s disease psychosis drug NUPLAZID drove growth.
The company raised its full-year DAYBUE sales out
Via MarketBeat · November 4, 2026
What Clover Health Investments (CLOV) Said on Its Q3 Earnings Callmarketbeat.com
Clover Health Investments (NASDAQ:CLOV) raised the lower end of its 2026 financial guidance after reporting a third-quarter profit, and said it expects to achieve its first full year of GAAP net income profitability.
The Medicare Advantage insurer reported third-quarter revenue of $759 million, up
Via MarketBeat · November 4, 2026
What Beyond Meat (BYND) Said on Its Q3 Earnings Callmarketbeat.com
Beyond Meat (NASDAQ:BYND) reported a narrower third-quarter loss and its highest gross margin in five years, but revenue continued to fall as weaker U.S. demand and lower international food-service sales outweighed growth in international retail.
The plant-based food company reported revenue of $64
Via MarketBeat · November 4, 2026
Arcutis Biotherapeutics Q3 Earnings Call Highlightsmarketbeat.com
Arcutis Biotherapeutics (NASDAQ:ARQT) raised its full-year 2026 net revenue guidance after third-quarter sales of its ZORYVE skin treatments rose 45% from a year earlier, driven primarily by increased patient demand.
The company reported $143.9 million in third-quarter net product revenue, up 11% f
Via MarketBeat · November 4, 2026
Enerpac Tool Group Targets $1 Billion in Revenue by 2030 With New Growth Planmarketbeat.com
Enerpac Tool Group (NYSE:EPAC) outlined a plan to grow organic revenue faster than its markets through fiscal 2030, while integrating its newly acquired SFE fabrication tools business and expanding profit margins.
At its 2026 Investor Day, the company introduced a growth strategy called PROPEL and
Via MarketBeat · November 4, 2026
What Cirrus Logic (CRUS) Said on Its Q2 Earnings Callmarketbeat.com
Cirrus Logic (NASDAQ:CRUS) reported fiscal second-quarter revenue of $559.5 million, up 22% from the prior quarter, as higher smartphone volumes and increased content per device helped offset weaker PC and general-market sales.
The chipmaker forecast revenue of $510 million to $570 million for the
Via MarketBeat · November 4, 2026
What AppLovin (APP) Said on Its Q3 Earnings Callmarketbeat.com
AppLovin (NASDAQ:APP) reported record third-quarter 2026 revenue of $2.18 billion, up 55% from a year earlier, as improvements to its advertising models helped drive growth in mobile gaming and consumer advertising.
Both revenue and adjusted EBITDA exceeded the high end of the company’s guidance. C
Via MarketBeat · November 4, 2026
Billiontoone Q3 Earnings Call Highlightsmarketbeat.com
Billiontoone (NASDAQ:BLLN) raised its full-year revenue outlook after third-quarter sales rose 47% from a year earlier, driven by growth in both prenatal and oncology testing. The molecular diagnostics company also reported its fifth consecutive quarter of positive GAAP operating income.
Revenue fo
Via MarketBeat · November 4, 2026
Adaptive Biotechnologies Q3 Earnings Call Highlightsmarketbeat.com
Adaptive Biotechnologies (NASDAQ:ADPT) reported third-quarter net income and raised its full-year revenue outlook for its minimal residual disease business, as demand for its clonoSEQ cancer testing service increased in both clinical care and drug development.
The company reported total revenue of
Via MarketBeat · November 4, 2026
Anadarko Petroleum Q3 Earnings Call Highlightsmarketbeat.com
ARKO Petroleum reported higher third-quarter earnings and raised its full-year adjusted EBITDA outlook, as stronger fuel margins offset lower sales volumes and the company worked toward closing an acquisition in the fourth quarter.
Net income rose to $13.3 million from $10.1 million a year earlier.
Via MarketBeat · November 4, 2026
Alto Ingredients Q3 Earnings Call Highlightsmarketbeat.com
Alto Ingredients (NASDAQ:ALTO) reported a fifth consecutive quarter of positive gross profit, operating income, net income and adjusted EBITDA, while raising its expectations for 2026 clean fuel tax credit earnings.
On its Nov. 4 earnings call, the producer of specialty alcohols, renewable fuel and
Via MarketBeat · November 4, 2026
What Ascent Industries (ACNT) Said on Its Q3 Earnings Callmarketbeat.com
Ascent Industries (NASDAQ:ACNT) reported higher third-quarter sales and adjusted earnings as organic growth and its Midwest Graphic Sales acquisition helped lift revenue, though executives cautioned that seasonal product demand would compress margins in the fourth quarter.
Third-quarter net sales r
Via MarketBeat · November 4, 2026
What Pacific Biosciences of California (PACB) Said on Its Q3 Earnings Callmarketbeat.com
Pacific Biosciences of California (NASDAQ:PACB) reported 6% revenue growth for the third quarter of 2026 as customers adopted its SPRQ-Nx sequencing chemistry, though consumables revenue declined from a year earlier and academic funding constraints continued to weigh on instrument purchases in the A
Via MarketBeat · November 4, 2026
ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Studymarketbeat.com
ADC Therapeutics (NYSE:ADCT) outlined new lymphoma data and plans for further studies of its cancer drug ZYNLONTA, while reporting preliminary third-quarter sales of approximately $21 million and an expected cash runway into 2029.
The company said Wednesday that five oral presentations and multiple
Via MarketBeat · November 4, 2026
Grand Canyon Education Q3 Earnings Call Highlightsmarketbeat.com
Grand Canyon Education (NASDAQ:LOPE) reported 2.4% revenue growth for the third quarter of 2026, but weaker-than-expected new enrollments at Grand Canyon University’s traditional campus prompted the company to lower its revenue outlook and projected operating margin.
Service revenue rose to $267.3
Via MarketBeat · November 4, 2026
What LegalZoom.com (LZ) Said on Its Q3 Earnings Callmarketbeat.com
LegalZoom.com (NASDAQ:LZ) lowered its full-year adjusted earnings outlook after a tougher customer acquisition environment weighed on business formations in the third quarter, even as subscription revenue continued to grow.
The company reported third-quarter revenue of $195 million, up 3% from a ye
Via MarketBeat · November 4, 2026
Myriad Genetics Q3 Earnings Call Highlightsmarketbeat.com
Myriad Genetics (NASDAQ:MYGN) reported third-quarter revenue of $202.7 million, down 1% from a year earlier, as growth in cancer and mental health testing was offset by a decline in its prenatal business. The company raised its full-year revenue outlook and said early efforts to address reimbursemen
Via MarketBeat · November 4, 2026
Cytek Biosciences Q3 Earnings Call Highlightsmarketbeat.com
Cytek Biosciences (NASDAQ:CTKB) reported third-quarter 2026 revenue of $53.2 million, up 2% from a year earlier, as growth in the U.S. and demand for its high-end instruments helped offset weakness in Asia-Pacific.
The flow cytometry company narrowed its full-year revenue guidance to $208 million t
Via MarketBeat · November 4, 2026
Fatpipe Inc/UT Q2 Earnings Call Highlightsmarketbeat.com
Fatpipe Inc/UT (NASDAQ:FATN) reported a 22% increase in second-quarter revenue and a return to profitability, as recurring billings rose and the networking company began selling a new network-monitoring product.
Revenue was approximately $4.83 million for the quarter ended September 30, 2026, Chief
Via MarketBeat · November 4, 2026
What Energy Recovery (ERII) Said on Its Q3 Earnings Callmarketbeat.com
Energy Recovery (NASDAQ:ERII) said desalination megaproject contracting has rebounded in the Middle East, with more than $30 million in new contracts signed over the past 30 days and a record project pipeline of about $525 million.
Interim President and CEO Alex Buehler said construction has resume
Via MarketBeat · November 4, 2026
ADMA Biologics Q3 Earnings Call Highlightsmarketbeat.com
ADMA Biologics (NASDAQ:ADMA) raised its minimum full-year earnings expectations after third-quarter profit rose on stronger sales of ASCENIV and improved manufacturing yields, even as competitive pressure weighed on its BIVIGAM product.
The company reported third-quarter revenue of $141.1 million,
Via MarketBeat · November 4, 2026
What American Bitcoin (ABTC) Said on Its Q3 Earnings Callmarketbeat.com
American Bitcoin (NASDAQ:ABTC) reported third-quarter net income of approximately $126 million, reversing a second-quarter loss, as gains on its Bitcoin holdings offset pressure on mining margins from higher energy costs.
The company mined approximately 891 Bitcoin during the quarter, down from 932
Via MarketBeat · November 4, 2026
Greif Q4 Earnings Call Highlightsmarketbeat.com
Greif (NYSE:GEF) reported higher fiscal 2026 earnings despite weak industrial demand and set a higher cost-savings target as it forecast further growth in adjusted EBITDA and free cash flow for fiscal 2027.
Adjusted EBITDA rose nearly 12% to $625.7 million for fiscal 2026, while adjusted earnings p
Via MarketBeat · November 4, 2026
Brookfield Renewable Partners Q3 Earnings Call Highlightsmarketbeat.com
Brookfield Renewable Partners (NYSE:BEP) reported record third-quarter funds from operations, as newly commissioned projects and gains from asset sales supported growth. The company also extended the voting deadline for its proposed corporate simplification after participation by unitholders fell sh
Via MarketBeat · November 4, 2026
What Claros Mortgage Trust (CMTG) Said on Its Q3 Earnings Callmarketbeat.com
Claros Mortgage Trust (NYSE:CMTG) reported a third-quarter loss and said it plans to continue selling troubled loans and real estate assets while reducing debt, as elevated interest rates weigh on commercial real estate values.
The company reported a GAAP net loss of $0.10 per share and a distribut
Via MarketBeat · November 4, 2026
What Brookfield Renewable (BEPC) Said on Its Q3 Earnings Callmarketbeat.com
Brookfield Renewable (NYSE:BEPC) reported record third-quarter funds from operations as newly commissioned projects and asset sales helped lift results, while management said it expects full-year earnings growth to meet or exceed its long-term targets.
The renewable power company generated funds fr
Via MarketBeat · November 4, 2026
What Viridian Therapeutics (VRDN) Said on Its Q3 Earnings Callmarketbeat.com
Viridian Therapeutics (NASDAQ:VRDN) reported $24.7 million in net product revenue from Lumvoa in the thyroid eye disease treatment’s first quarter on the market, with more than 100 patients having received at least one infusion by Sept. 30.
President and CEO Steve Mahoney said the launch exceeded t
Via MarketBeat · November 4, 2026
What XPEL (XPEL) Said on Its Q3 Earnings Callmarketbeat.com
XPEL (NASDAQ:XPEL) reported higher third-quarter revenue and earnings as gross margin improved, but the company forecast a slowdown in fourth-quarter sales growth amid weakness in U.S. dealerships and the aftermarket.
Revenue rose 9.9% to $137.8 million in the third quarter of 2026, while net incom
Via MarketBeat · November 4, 2026
Adient Q4 Earnings Call Highlightsmarketbeat.com
Adient (NYSE:ADNT) expects higher adjusted earnings in fiscal 2027 despite declining vehicle production and lower sales, as the automotive seating supplier relies on cost reductions and recoveries from customers to offset pressure from tariffs, commodities and changing vehicle mix.
The company repo
Via MarketBeat · November 4, 2026
Urogen Pharma Q3 Earnings Call Highlightsmarketbeat.com
Urogen Pharma (NASDAQ:URGN) reported third-quarter revenue of $89 million, more than triple the $27.5 million recorded a year earlier, as sales of bladder cancer treatment ZUSDURI continued to grow. The company said it expects to achieve profitability and generate positive cash flow in the fourth qu
Via MarketBeat · November 4, 2026
What United Therapeutics (UTHR) Said on Its Q3 Earnings Callmarketbeat.com
United Therapeutics (NASDAQ:UTHR) reported record third-quarter 2026 revenue of $833 million, driven in part by record Tyvaso sales of $504 million, while pushing back a planned regulatory submission for its soft mist inhaler to 2027.
President and Chief Operating Officer Michael Benkowitz said the
Via MarketBeat · November 4, 2026
What Trinity Capital (TRIN) Said on Its Q3 Earnings Callmarketbeat.com
Trinity Capital (NASDAQ:TRIN) reported third-quarter net investment income of $0.52 per share, covering its $0.51 quarterly distribution, as investment income and assets under management rose from a year earlier.
The business development company generated $98 million in total investment income, up
Via MarketBeat · November 4, 2026
What Assurant (AIZ) Said on Its Q3 Earnings Callmarketbeat.com
Assurant (NYSE:AIZ) reported broad-based earnings growth in the third quarter, led by gains in its Global Lifestyle and Global Housing segments, and raised its outlook for full-year 2026 adjusted EBITDA and adjusted earnings per share growth.
President and Chief Executive Officer Keith Demmings sai
Via MarketBeat · November 4, 2026
Rallybio Stockholders Approve Avenzo Merger, Name Change and Reverse Splitmarketbeat.com
Rallybio (NASDAQ:RLYB) stockholders approved a series of proposals tied to the company’s planned merger with Avenzo Therapeutics Inc., including the issuance of Rallybio shares to Avenzo security holders and corporate actions that would take effect in connection with the transaction.
At Rallybio’s
Via MarketBeat · November 4, 2026
American International Group Q3 Earnings Call Highlightsmarketbeat.com
American International Group (NYSE:AIG) reported third-quarter adjusted after-tax income of $1.1 billion, or $2.06 per diluted share, as growth in underwriting income and net investment income helped offset a less favorable catastrophe-loss comparison with the prior-year period.
Core operating retu
Via MarketBeat · November 4, 2026
What Taboola.com (TBLA) Said on Its Q3 Earnings Callmarketbeat.com
Taboola.com (NASDAQ:TBLA) reported third-quarter results in line with its guidance, while lowering its full-year ex-TAC gross profit outlook as changes in consumer behavior affected advertising impressions across its publisher network.
Founder and CEO Adam Singolda said the company generated $188.8
Via MarketBeat · November 4, 2026
United Fire Group Q3 Earnings Call Highlightsmarketbeat.com
United Fire Group (NASDAQ:UFCS) reported a 94.6% combined ratio for the third quarter of 2026, extending what President and Chief Executive Officer Kevin Leidwinger described as strong operating performance through the first nine months of the year. The insurer said its results contributed to record
Via MarketBeat · November 4, 2026
What UFP Technologies (UFPT) Said on Its Q3 Earnings Callmarketbeat.com
UFP Technologies (NASDAQ:UFPT) reported third-quarter 2026 sales growth of 11.6%, supported by broad demand across its medical technology portfolio, while management outlined continued investments in capacity, operational improvements and acquisitions heading into 2027.
Third-quarter sales totaled
Via MarketBeat · November 4, 2026
American Financial Group Q3 Earnings Call Highlightsmarketbeat.com
American Financial Group (NYSE:AFG) reported record third-quarter core operating results, supported by underwriting profitability, premium growth and higher property and casualty investment income, executives said during the company’s third-quarter 2026 earnings call.
Core net operating earnings we
Via MarketBeat · November 4, 2026
Twin Disc Q1 Earnings Call Highlightsmarketbeat.com
Twin Disc (NASDAQ:TWIN) reported higher fiscal first-quarter 2027 sales, earnings and cash generation, supported by demand across its marine, industrial, energy and defense markets. Management said defense-related orders, particularly from European NATO customers and U.S. Navy unmanned-vessel progra
Via MarketBeat · November 4, 2026
Weyco Group Q3 Earnings Call Highlightsmarketbeat.com
Weyco Group (NASDAQ:WEYS) reported higher third-quarter sales and earnings, aided by growth across several footwear brands, lower incremental tariff rates and the recognition of tariff refunds in cost of sales.
Net sales for the third quarter of 2026 increased 5% year over year to $77 million. Net
Via MarketBeat · November 4, 2026
Neuronetics Q3 Earnings Call Highlightsmarketbeat.com
Neuronetics (NASDAQ:STIM) reported third-quarter 2026 revenue growth, wider gross margin and a return to positive adjusted EBITDA, citing record NeuroStar system sales and continued revenue-cycle improvements across its Greenbrook clinic network.
Total revenue rose 12.5% year over year to $42 milli
Via MarketBeat · November 4, 2026
Trivago N.V. ADS Q3 Earnings Call Highlightsmarketbeat.com
Trivago N.V. ADS (NASDAQ:TRVG) reported third-quarter revenue growth of 16% year over year to EUR 192.5 million, marking its seventh consecutive quarter of double-digit growth. The company posted net income of EUR 5.4 million and Adjusted EBITDA of EUR 18.7 million, which management said was its hig
Via MarketBeat · November 4, 2026
What Solstice Advanced Mat (SOLS) Said on Its Q3 Earnings Callmarketbeat.com
Solstice Advanced Mat (NASDAQ:SOLS) reported third-quarter 2026 results that exceeded its sales guidance, driven by growth in electronic materials, refrigerants and healthcare packaging. The company also raised its full-year outlook for the second consecutive quarter, citing continued momentum acros
Via MarketBeat · November 4, 2026
What Torm (TRMD) Said on Its Q3 Earnings Callmarketbeat.com
Torm (NASDAQ:TRMD) reported higher third-quarter earnings as strong product tanker markets lifted freight rates across its fleet, while the company expanded its newbuilding pipeline and raised the low end of its full-year guidance.
Third-quarter time-charter equivalent, or TCE, earnings rose to $35
Via MarketBeat · November 4, 2026
Royalty Pharma Q3 Earnings Call Highlightsmarketbeat.com
Royalty Pharma (NASDAQ:RPRX) reported third-quarter portfolio receipts of $890 million, up 9% from a year earlier, as growth in its diversified royalty portfolio offset declines in certain products. The company raised its full-year 2026 outlook for the third consecutive quarter, citing continued mom
Via MarketBeat · November 4, 2026
Reservoir Media Q2 Earnings Call Highlightsmarketbeat.com
Reservoir Media (NASDAQ:RSVR) reported fiscal second-quarter revenue growth and raised its full-year outlook, citing gains in both its music publishing and recorded music businesses as the company continued adding songwriter relationships and acquiring catalogs.
For the quarter ended Sept. 30, 2026
Via MarketBeat · November 4, 2026
What Trimble (TRMB) Said on Its Q3 Earnings Callmarketbeat.com
Trimble (NASDAQ:TRMB) reported third-quarter revenue of $967 million, up 7% year over year, and non-GAAP earnings per share of $0.86, which the company said was in line with and above the midpoint of its guidance range. Annualized recurring revenue reached a record $2.564 billion, up 10%, while EBIT
Via MarketBeat · November 4, 2026
Shoals Technologies Group Q3 Earnings Call Highlightsmarketbeat.com
Shoals Technologies Group (NASDAQ:SHLS) and ARRAY Technologies announced plans to combine in a stock-for-stock merger, forming an integrated energy-infrastructure platform focused on utility-scale solar and adjacent markets. The companies expect the transaction to close in the first quarter of 2027,
Via MarketBeat · November 4, 2026
What SLR Investment (SLRC) Said on Its Q3 Earnings Callmarketbeat.com
SLR Investment (NASDAQ:SLRC) reported third-quarter net investment income of $17.8 million, or $0.33 per average share, exceeding its quarterly distribution of $0.31 per share. The business development company said its net asset value declined to $17.83 per share as of Sept. 30 from $18.00 at the en
Via MarketBeat · November 4, 2026